Cargando…

Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years

We herein report a woman with chronic inflammatory demyelinating polyneuropathy (CIDP) in whom positivity for anti-neurofascin 155 antibodies was revealed 23 years after the onset of neuropathy. The patient initially reported numbness in the face at 50 years of age and subsequently manifested featur...

Descripción completa

Detalles Bibliográficos
Autores principales: Koike, Haruki, Nishi, Ryoji, Ikeda, Shohei, Kawagashira, Yuichi, Iijima, Masahiro, Atsuta, Naoki, Nakamura, Tomohiko, Hirayama, Masaaki, Ogata, Hidenori, Yamasaki, Ryo, Kira, Jun-ichi, Katsuno, Masahisa, Sobue, Gen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096034/
https://www.ncbi.nlm.nih.gov/pubmed/29491293
http://dx.doi.org/10.2169/internalmedicine.0455-17
_version_ 1783348036881088512
author Koike, Haruki
Nishi, Ryoji
Ikeda, Shohei
Kawagashira, Yuichi
Iijima, Masahiro
Atsuta, Naoki
Nakamura, Tomohiko
Hirayama, Masaaki
Ogata, Hidenori
Yamasaki, Ryo
Kira, Jun-ichi
Katsuno, Masahisa
Sobue, Gen
author_facet Koike, Haruki
Nishi, Ryoji
Ikeda, Shohei
Kawagashira, Yuichi
Iijima, Masahiro
Atsuta, Naoki
Nakamura, Tomohiko
Hirayama, Masaaki
Ogata, Hidenori
Yamasaki, Ryo
Kira, Jun-ichi
Katsuno, Masahisa
Sobue, Gen
author_sort Koike, Haruki
collection PubMed
description We herein report a woman with chronic inflammatory demyelinating polyneuropathy (CIDP) in whom positivity for anti-neurofascin 155 antibodies was revealed 23 years after the onset of neuropathy. The patient initially reported numbness in the face at 50 years of age and subsequently manifested features compatible to typical CIDP. Steroid administration initiated at 54 years of age ameliorated her neuropathic symptoms. Although the nerve conduction indices at 59 years of age deteriorated, those at 68, 72, and 73 years of age showed a gradual recovery. The deterioration and subsequent restoration of compound muscle action potential amplitudes was the most dramatic, suggesting that a conduction block can be reversed earlier than other electrophysiological indices.
format Online
Article
Text
id pubmed-6096034
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-60960342018-08-17 Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years Koike, Haruki Nishi, Ryoji Ikeda, Shohei Kawagashira, Yuichi Iijima, Masahiro Atsuta, Naoki Nakamura, Tomohiko Hirayama, Masaaki Ogata, Hidenori Yamasaki, Ryo Kira, Jun-ichi Katsuno, Masahisa Sobue, Gen Intern Med Case Report We herein report a woman with chronic inflammatory demyelinating polyneuropathy (CIDP) in whom positivity for anti-neurofascin 155 antibodies was revealed 23 years after the onset of neuropathy. The patient initially reported numbness in the face at 50 years of age and subsequently manifested features compatible to typical CIDP. Steroid administration initiated at 54 years of age ameliorated her neuropathic symptoms. Although the nerve conduction indices at 59 years of age deteriorated, those at 68, 72, and 73 years of age showed a gradual recovery. The deterioration and subsequent restoration of compound muscle action potential amplitudes was the most dramatic, suggesting that a conduction block can be reversed earlier than other electrophysiological indices. The Japanese Society of Internal Medicine 2018-02-28 2018-07-15 /pmc/articles/PMC6096034/ /pubmed/29491293 http://dx.doi.org/10.2169/internalmedicine.0455-17 Text en Copyright © 2018 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Koike, Haruki
Nishi, Ryoji
Ikeda, Shohei
Kawagashira, Yuichi
Iijima, Masahiro
Atsuta, Naoki
Nakamura, Tomohiko
Hirayama, Masaaki
Ogata, Hidenori
Yamasaki, Ryo
Kira, Jun-ichi
Katsuno, Masahisa
Sobue, Gen
Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years
title Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years
title_full Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years
title_fullStr Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years
title_full_unstemmed Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years
title_short Restoration of a Conduction Block after the Long-term Treatment of CIDP with Anti-neurofascin 155 Antibodies: Follow-up of a Case over 23 Years
title_sort restoration of a conduction block after the long-term treatment of cidp with anti-neurofascin 155 antibodies: follow-up of a case over 23 years
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096034/
https://www.ncbi.nlm.nih.gov/pubmed/29491293
http://dx.doi.org/10.2169/internalmedicine.0455-17
work_keys_str_mv AT koikeharuki restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT nishiryoji restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT ikedashohei restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT kawagashirayuichi restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT iijimamasahiro restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT atsutanaoki restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT nakamuratomohiko restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT hirayamamasaaki restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT ogatahidenori restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT yamasakiryo restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT kirajunichi restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT katsunomasahisa restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years
AT sobuegen restorationofaconductionblockafterthelongtermtreatmentofcidpwithantineurofascin155antibodiesfollowupofacaseover23years